Gout and risk of chronic kidney disease and nephrolithiasis: meta-analysis of observational studies
- PMID: 25889144
- PMCID: PMC4404569
- DOI: 10.1186/s13075-015-0610-9
Gout and risk of chronic kidney disease and nephrolithiasis: meta-analysis of observational studies
Abstract
Introduction: To determine the prevalence of chronic kidney disease and nephrolithiasis in people with gout, and the association between gout and prevalent or incident chronic kidney disease and nephrolithiasis.
Methods: Systematic review and meta-analysis of epidemiological studies. Data sources; MEDLINE, EMBASE and CINAHL databases, hand-searched reference lists, citation history and contact with authors.
Eligibility criteria: cohort, case-control or cross-sectional studies which examined the occurrence of chronic kidney disease or nephrolithiasis amongst adults with gout (with or without a non-gout comparator group) in primary care or general population samples. Prevalence and risk estimate meta-analyses were performed using a random-effects model.
Results: Seventeen studies were included in the meta-analysis (chronic kidney disease n = 7, nephrolithiasis n = 8, both n = 2). Pooled prevalence estimates of chronic kidney disease stage ≥3 and self-reported lifetime nephrolithiasis in people with gout were 24% (95% confidence interval 19% to 28%) and 14% (95% CI 12% to 17%) respectively. Gout was associated with both chronic kidney disease (pooled adjusted odds ratio 2.41, 95% confidence interval 1.86 to 3.11) and self-reported lifetime nephrolithiasis (1.77, 1.43 to 2.19).
Conclusions: Chronic kidney disease and nephrolithiasis are commonly found amongst patients with gout. Gout is independently associated with both chronic kidney disease and nephrolithiasis. Patients with gout should be actively screened for chronic kidney disease and its consequences.
Figures





Similar articles
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2020 Jan 9;1:CD011535. doi: 10.1002/14651858.CD011535.pub3. PMID: 29271481 Free PMC article. Updated.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 May 23;5:CD011535. doi: 10.1002/14651858.CD011535.pub5. PMID: 33871055 Free PMC article. Updated.
-
Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.Health Technol Assess. 2010 Apr;14(21):1-184. doi: 10.3310/hta14210. Health Technol Assess. 2010. PMID: 20441712
-
Home versus in-centre haemodialysis for people with kidney failure.Cochrane Database Syst Rev. 2024 Apr 8;4(4):CD009535. doi: 10.1002/14651858.CD009535.pub3. Cochrane Database Syst Rev. 2024. PMID: 38588450 Free PMC article.
-
Early and late renal adverse effects after potentially nephrotoxic treatment for childhood cancer.Cochrane Database Syst Rev. 2013 Oct 8;(10):CD008944. doi: 10.1002/14651858.CD008944.pub2. Cochrane Database Syst Rev. 2013. Update in: Cochrane Database Syst Rev. 2019 Mar 11;3:CD008944. doi: 10.1002/14651858.CD008944.pub3. PMID: 24101439 Updated.
Cited by
-
Cardiovascular risk factors, ethnicity and infection stone are independent factors associated with reduced renal function in renal stone formers.PLoS One. 2022 Apr 14;17(4):e0265510. doi: 10.1371/journal.pone.0265510. eCollection 2022. PLoS One. 2022. PMID: 35421118 Free PMC article.
-
Epidemiology and diagnosis of gout in sub-saharan Africa: a scoping review.BMC Rheumatol. 2024 May 23;8(1):21. doi: 10.1186/s41927-024-00391-w. BMC Rheumatol. 2024. PMID: 38783360 Free PMC article.
-
Effect of Bining decoction on gouty nephropathy: a network pharmacology analysis and preliminary validation of gut microbiota in a mouse model.Ann Transl Med. 2022 Dec;10(23):1271. doi: 10.21037/atm-22-5523. Ann Transl Med. 2022. PMID: 36618800 Free PMC article.
-
Excess Uric Acid Induces Gouty Nephropathy Through Crystal Formation: A Review of Recent Insights.Front Endocrinol (Lausanne). 2022 Jul 14;13:911968. doi: 10.3389/fendo.2022.911968. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35909538 Free PMC article. Review.
-
An evaluation of longitudinal changes in serum uric acid levels and associated risk of cardio-metabolic events and renal function decline in gout.PLoS One. 2018 Feb 28;13(2):e0193622. doi: 10.1371/journal.pone.0193622. eCollection 2018. PLoS One. 2018. PMID: 29489919 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical